Rare diseases
Investigational molecules
Locations
Ulitsa Mladost 8, 4002 Plovdiv, Bulgaria
Medical Center Artmed Ltd. in Plovdiv, Bulgaria specialises in clinical trials of conditions such as Psoriatic arthropathy, Systemic lupus erythematosus, Dermatomyositis, Polymyositis, and other specialisations. This site conducts important research.
The research at Medical Center Artmed Ltd. emphasizes autoimmune conditions such as systemic lupus erythematosus, aiming to evaluate new therapies that can lower disease activity and improve patient quality of life.
The site collaborates with regional hospitals to ensure robust trial oversight and patient safety.
Clinical investigations include post‑menopausal osteoporosis and inflammatory muscle disorders, with a focus on improving bone density and muscle strength in affected adults.
Participants benefit from comprehensive monitoring and access to emerging therapeutic options.
Investigations target core immune mechanisms, such as cytokine signaling pathways, to support the development of precision medicines for autoimmune diseases.
The program integrates laboratory expertise from European research networks.
The center explores processes like autoantibody production and complement activation to refine diagnostic tools and predict therapeutic response.
Patient involvement is guided by strict ethical standards and continuous safety oversight.
Research assesses muscle inflammation and neuromuscular function in idiopathic inflammatory myopathies, seeking to enhance therapeutic outcomes and functional recovery.
Located in Plovdiv, Bulgaria, the site provides a multidisciplinary environment for innovative trial conduct.
Clinical trials currently enrolling participants at this site.
Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
BulgariaStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
BulgariaStudy on Anifrolumab for Adults with Polymyositis or Dermatomyositis
BulgariaEvaluation of Long-Term Safety and Efficacy of Litifilimab in Adults with Active Systemic Lupus Erythematosus: A Phase 3 Multicenter, Randomized, Dose-Blind Study
BulgariaStudy on the Long-Term Safety of Dazukibart in Patients with Idiopathic Inflammatory Myopathies, Including Dermatomyositis and Polymyositis
BulgariaStudy on the Effectiveness of Dazukibart in Adults with Active Dermatomyositis or Polymyositis
BulgariaA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
BulgariaStudy on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis
BulgariaA Phase 2 Study of LAD603 in Adults with Systemic Lupus Erythematosus and Active Skin Rash
BulgariaELV001 for Active Rheumatoid Arthritis in Patients with Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition
BulgariaStudy of human normal immunoglobulin to prevent major infections in patients with hypogammaglobulinemia and autoimmune/rheumatic disease on B‑cell depletion therapy
BulgariaStudy on the Effectiveness and Safety of Nipocalimab for Adults with Moderate to Severe Sjögren's Disease
BulgariaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
